noun.
A characteristic shared by a group of immunoglobulin or T cell receptor molecules, based on the antigen binding specificity of their variable region
Word Usage
"Favrille spent more than $140 million on the development of a portfolio of biotech assets and related patents including the FavId™ idiotype vaccine that was the Company's lead product candidate for the treatment of B-cell Non-Hodgkin's Lymphoma."